Literature DB >> 7096985

2,4-D induced clastogenicity and elevated rates of sister chromatid exchanges in cultured human lymphocytes.

C Korte, S M Jalal.   

Abstract

Potential for genetic damage in future generations from such widely used hormonic herbicide as 2,4-D (2,4-dichlorophenoxyacetic acid) is of serious concern. Yet the data, particularly on mammalian systems, continue to be inadequate and inconclusive. An attempt was made in this study to determine the clastogenic and mutagenic potential of 2,4-D in cultured lymphocytes. Chromosome damage though statistically insignificant occurred at dosages as low as 0.2 microgram/ml. Chromosome damage was increased at a statistically significant level whenever the concentration was 50 microgram/ml or higher. Mutagenicity, based on rates of increase in sister chromatid exchanges, was significant at 10 micrograms/ml of higher concentrations. Statistical testing was based o analysis of variance, Dunnett's multiple comparison tests and linear regressions. It seems imperative therefore to avoid indiscriminate use of 2,4-D, and to test the compound for long-range low-level exposures.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7096985     DOI: 10.1093/oxfordjournals.jhered.a109622

Source DB:  PubMed          Journal:  J Hered        ISSN: 0022-1503            Impact factor:   2.645


  3 in total

1.  In vitro genotoxicity assessment of the synthetic plant growth regulator, 1-naphthaleneacetamide.

Authors:  Ayşe Yavuz Kocaman; Banu Güven
Journal:  Cytotechnology       Date:  2015-02-19       Impact factor: 2.058

2.  Comparison of the cytotoxicity and DNA-damaging properties of 2,4-D and U 46 D fluid (dimethylammonium salt of 2,4-D).

Authors:  M Clausen; G Leier; I Witte
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

3.  A Systematic Review of Carcinogenic Outcomes and Potential Mechanisms from Exposure to 2,4-D and MCPA in the Environment.

Authors:  Katherine von Stackelberg
Journal:  J Toxicol       Date:  2013-02-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.